FIELD: chemical- -pharmaceutical industry. SUBSTANCE: injection or infusion solution has enrofloxacin in the amount from 0.1 to 20 wt.% as measured for total solution weight, in the form of salts with polyhydroxycarboxylic acids or amino acids or their mixtures, polyhydroxycarboxylic acids, amino acids or their mixtures at 0.1-5-fold molar excess as measured for enrofloxacin and water up to 100 wt.%. Invention provides the rapid high level of biologically active substance in blood. EFFECT: accelerated development of high activity of drug. 2 cl, 7 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ENROFLOXACIN BASED TREATMENT OF MASTITIS | 2005 |
|
RU2413514C2 |
| INJECTION SOLUTION FOR TREATING VIRAL DISEASES SPECIFIED IN H1N1, H3N2, H5N1 INFLUENZA, TICK-BORNE ENCEPHALITIS AND WEST NILE FEVER | 2013 |
|
RU2574007C2 |
| SODIUM CHLORIDE-CONTAINING MOXIFLOXACIN COMPOSITIONS | 2000 |
|
RU2260429C9 |
| METHOD OF PRODUCING ANTIBACTERIAL SOLUTION | 0 |
|
SU1384187A3 |
| METHOD OF PREPARING THE PRESERVED MEDICINAL AGENT CONTAINING HUMAN PROTEIN FOR INJECTION OR INFUSION ADMINISTRATION | 1992 |
|
RU2091068C1 |
| DERIVATIVES OF PYRIDOBENZOXADIAZINE CARBOXYLIC ACID, MIXTURE OF THEIR ISOMERS OR SEPARATE ISOMERS, THEIR PHARMACEUTICALLY USED HYDRATES AND SALTS AND PHARMACEUTICAL COMPOSITION SHOWING ANTIBACTERIAL ACTIVITY ON THEREOF | 1995 |
|
RU2138504C1 |
| METHOD OF PREPARING 3-QUINOLONECARBOXYLIC ACID DERIVATIVES | 1994 |
|
RU2138483C1 |
| NEW APPLICATION OF QUINOLONE ANTIBIOTICS | 2004 |
|
RU2367437C2 |
| METHOD OF PREPARING INJECTION SOLUTION OF 2-MERCAPTOETHANE SULFONATE SODIUM (MESNA) | 1993 |
|
RU2105550C1 |
| BENZIMIDAZOLE DERIVATIVES AND THEIR ACID-ADDITION SALTS, METHOD OF PREPARATION THEREOF, AND HERBICIDE AGENT BASED ON THESE COMPOUNDS | 1996 |
|
RU2159242C2 |
